| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |